Use of arsenic compounds for treatment of pain and inflammation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 33/36 (2006.01) A61P 29/00 (2006.01) A61P 37/06 (2006.01)

Patent

CA 2677388

The present invention relates to the use of arsenic compounds such as sodium meta arsenite (NaAsO2), arsenic trioxide (AS2O3), and arsenic hexoxide (As4O6) or combinations thereof, for the treatment of painful, hyperalgesic and/or inflammatory conditions. The present invention also relates to compositions containing the above arsenic compounds for use in the treatment of pain, inflammation and immunological and autoimmune diseases and disorders.

La présente invention concerne l'utilisation de composés à l'arsenic, tels le sodium méta-arsénite (NaAsO2), le trioxyde d'arsenic (AS2O3) et un hexoxyde d'arsenic (As4O6) ou leurs combinaisons, en vue de traiter des états douloureux, hyperalgésiques et/ou inflammatoires. La présente invention porte aussi sur des compositions contenant les composés à l'arsenic susmentionnés, destinées à être utilisées dans le traitement de la douleur, des inflammations et des maladies et troubles immunologiques et auto-immuns.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of arsenic compounds for treatment of pain and inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of arsenic compounds for treatment of pain and inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of arsenic compounds for treatment of pain and inflammation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1940243

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.